Drug intelligence / Profile preview

Klimaktoplant H

Development stage: Unknown
Lead developer: Deutsche Homöopathie-Union
Modality: Small Molecules
Administration: Oral

Overview

Klimaktoplant H is a non-hormonal, homeopathic medicinal product developed by Deutsche Homöopathie-Union (DHU) for the treatment of acute menopausal complaints. It is an oral tablet formulation containing a combination of four homeopathic triturations: *Cimicifuga racemosa* (D2), *Sepia officinalis* (D2), *Strychnos ignatii* (D3), and *Sanguinaria canadensis* (D6). The product is indicated for vasomotor, psychosomatic, and neurovegetative symptoms such as hot flushes, sweating, palpitations, vertigo, and emotional instability during the pre-, peri-, and early postmenopausal periods. It has been evaluated in Phase III clinical trials as a hormone-free alternative for managing menopause-related quality of life.

Brand names: Klimaktoplant HKlimaktoplant

Beyond the preview

Go deeper on Klimaktoplant H.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Klimaktoplant H.

Explore the full profile